Table 1.
Variable | Total (n=28 924) |
Age (years) | 37.82±9.27 |
20–29 | 5308 (18.35) |
30–39 | 12 338 (42.66) |
40–49 | 8019 (27.72) |
50–59 | 2674 (9.24) |
60–69 | 584 (2.02) |
≥70 | 1 (0.00) |
Gender | |
Male | 15 749 (54.45) |
Female | 13 175 (45.55) |
Academic degree | |
Junior college | 225 (0.78) |
Bachelor | 12 704 (43.92) |
Master | 10 580 (36.58) |
Doctor | 2905 (10.04) |
Post-doctor | 412 (1.42) |
Others | 2098 (7.25) |
Hospital level | |
Primary | 381 (1.32) |
Secondary | 10 823 (37.42) |
Tertiary | 17 375 (60.07) |
Others | 345 (1.19) |
Professional title | |
General physician | 4230 (14.62) |
Healer | 540 (1.87) |
Resident physician | 966 (3.34) |
Attending physician | 13 448 (46.49) |
Associate chief physician | 4674 (16.16) |
Chief physician | 2279 (7.88) |
Others | 2787 (9.64) |
BMI (kg/m2) | 22.35±2.51 |
<18.5 | 1475 (5.10) |
18.5–23.9 | 19 304 (66.74) |
≥24 | 8145 (28.16) |
Current disease | |
Coronary heart disease | 1760 (6.08) |
Heart failure | 554 (1.92) |
Diabetes | 598 (2.07) |
Stroke/transient ischaemic attack | 167 (0.58) |
Chronic kidney disease | 409 (1.41) |
Peripheral vascular disease | 431 (1.49) |
Hypertension | 7319 (25.30) |
Medication | |
Antihypertensive drugs | 2323 (8.03) |
Antidiabetic drugs | 574 (1.98) |
Lipid-lowering drugs | 1223 (4.23) |
Data are expressed as mean±SD or n (%).
BMI, body mass index.